Genes, proteins, and neurotoxins involved in Parkinson's disease.
about
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosisPossible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disordersBrain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicitySpontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein ExpressionNon-Linear EMG Parameters for Differential and Early Diagnostics of Parkinson's Disease.Neuroproteomics as a promising tool in Parkinson's disease research.Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines.Metabolomics and in-silico analysis reveal critical energy deregulations in animal models of Parkinson's disease.Genetic variants ofLRRK2 in Taiwanese Parkinson's diseaseChronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study.STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan.UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.Modeling neurodegenerative diseases in vivo review.Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan.Dangguijakyak-San Protects against 1-Methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-Induced Neuronal Damage via Anti-Inflammatory Action.Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy.Signaling with homeoprotein transcription factors in development and throughout adulthood.A network view on Parkinson's disease.Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease.The role of otx2 in adult mesencephalic-diencephalic dopaminergic neurons.Otx genes in neurogenesis of mesencephalic dopaminergic neurons.Agrochemicals, α-synuclein, and Parkinson's disease.Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat.The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.Dual effects of alpha-synuclein on neurotoxicity induced by low dosage of rotenone are dependent on exposure time in dopaminergic neuroblastoma cells.Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats.Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway.Fasciculation and elongation protein zeta-1 (FEZ1) expression in reactive astrocytes in a rat model of Parkinson's disease.Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study.Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease.
P2860
Q21266563-8F2B5309-680E-4DB0-BBC3-C3F2ED16435BQ28386662-32F53C13-DC2A-441D-B9A1-AB85A742B652Q28394667-0FB2AEF0-F403-491F-B516-C257BA701C58Q30359033-5A576EEE-EB3B-4C18-91D1-6B8B833B993AQ30449049-9CDFC515-FFAB-401C-BB03-4D0FE7BB0C65Q33821316-3C7D5D7B-7AB7-443E-9F7D-3F3FA837BAD1Q34179881-9996EAE5-66E3-441F-BFE1-4087314B31C8Q34257471-227717EB-B5B3-4B63-AC7A-7E38EA811F5BQ34919307-CB134D40-29D9-4C59-A003-A3AD9FB5A0BFQ35067666-F0107972-D364-48E8-B333-66B7897E48EAQ35252890-999C59AA-A54D-488F-8258-7966BA1CFBA4Q35893878-A312E8AB-CD37-4926-8238-A6A5DE31C3C7Q36195637-FBE4D7A0-C5D7-435E-BCE3-5D1D48AA8949Q36464299-EC155463-B88D-41D9-9553-46921C649D7AQ36565642-9D8E1610-9C3C-4273-8860-55F31C5090C4Q36566963-6277FE3B-2D63-4F1B-AD02-8EA4F773EA98Q37171891-D59CB094-D72E-41FA-AC26-0F98A4C70B3FQ37203372-B2F67236-114C-46B3-8F7F-CF1C354C4D36Q37389347-E636285D-353B-47C9-977D-9AEB4F1A17F5Q37655091-19F23BC7-7F19-419F-8E11-78C0D31D8DD1Q37692773-69C3969F-DD66-4CEF-8909-04C3EF5D3886Q37810501-9513E0F0-FEC8-49EA-96C9-7B1D0DA0249FQ37838914-F328C0DC-14F8-4046-8102-4250CA59CC42Q38039020-DFCC721F-7715-44CD-BF5F-CB74EF13A1F4Q38039857-276A9D23-A890-4854-8840-F20D7219C2C2Q39159132-96704FB1-568E-4144-A346-4062360C3981Q39179414-9361C0D6-12D0-44DA-A8D9-59A49904DA82Q39202533-2F0BE495-6246-4BAF-9525-BD974E5D17C2Q39205347-BCC825F9-CD38-4A09-BE50-DB4C9395AE71Q39392465-64282488-1036-4887-83E4-EBEAD5521E57Q39503922-1C3A3C82-A67C-450B-A4DE-642A637B48F7Q39685688-28D40D5F-77DE-4683-910D-62DD68BF6263Q40870236-E8E39803-D0FF-42D1-BBF9-0401FFB018FEQ46386528-172162AD-0B0E-4723-9D00-FA2A8D137ADFQ46933074-380E0268-09F1-4A4A-9998-B69B654CC984Q46958208-0CB52FA8-6960-48BA-A4E9-12855979B640Q47929850-87262F0B-17B3-455F-8522-927C7963F3F5Q48079319-A54BF63F-F032-4605-A572-46FB9C92888FQ48293950-D7E2B89E-6B91-4A63-AAEA-DFE8856C7D14Q48320615-E39FD3BD-BB61-4696-9C49-20023320C0BB
P2860
Genes, proteins, and neurotoxins involved in Parkinson's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genes, proteins, and neurotoxins involved in Parkinson's disease.
@ast
Genes, proteins, and neurotoxins involved in Parkinson's disease.
@en
type
label
Genes, proteins, and neurotoxins involved in Parkinson's disease.
@ast
Genes, proteins, and neurotoxins involved in Parkinson's disease.
@en
prefLabel
Genes, proteins, and neurotoxins involved in Parkinson's disease.
@ast
Genes, proteins, and neurotoxins involved in Parkinson's disease.
@en
P2093
P1476
Genes, proteins, and neurotoxins involved in Parkinson's disease.
@en
P2093
K Krieglstein
O von Bohlen und Halbach
P304
P356
10.1016/J.PNEUROBIO.2004.05.002
P577
2004-06-01T00:00:00Z